---
$id: https://graph.org.ai/products/commodity/51144122
$type: Product
source: UNSPSC
code: "51144122"
title: "Furfenorex"
class: "51144100"
classTitle: "Stimulant or anorexiant amphetamines"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Furfenorex

**UNSPSC Code**: 51144122
**Class**: [Stimulant or anorexiant amphetamines](Stimulant or anorexiant amphetamines.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anorexiant with the molecular formula C15H19NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) X83CZ0Y5TF, chemically known as 2-furanmethanamine, n-methyl-n-(1-methyl-2-phenylethyl)-, (+)- (9ci) but more generally known as furfenorex, which bears US NIH Compound Identifier 26762. European Medicines Agency schedules Furfenorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07840MIG. The term FURFENOREX is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). FURFENOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule furfenorex under HS 29321900 and SITC 51569. As of Q4 2014, FURFENOREX remains US FDA's Preferred Term for this commodity. Furfenorex bears US NLM identifiers UMLS ID C0060861 and NCI Concept Code C75113. SMILES: O1C(CN(C(CC2CCCCC2)C)C)CCC1.

